I am an experienced drug development physician with strong technical insight and an ability to negotiate complex environments where commercial, scientific and KOL-friendly leadership is required. My skill set includes the ability to place technical complexity in a more elegant and comprehensible framework whilst making sure that none of the nuance is lost. I work well within...
I am an experienced drug development physician with strong technical insight and an ability to negotiate complex environments where commercial, scientific and KOL-friendly leadership is required. My skill set includes the ability to place technical complexity in a more elegant and comprehensible framework whilst making sure that none of the nuance is lost. I work well within matrix environments and have enabled teams to deliver some awesome results.VP Oncology Drug development Services @ From June 2015 to Present (7 months) London, United KingdomVP Oncology @ Consulting, tactics/strategy and competitive intelligence for a boutique consultancy in a majorly competitive environment. From March 2014 to June 2015 (1 year 4 months) Group Medical director (CMO role) Immunocore/Adaptimmune @ My role for both Adaptimmune and Immunocore is to provide a) pivotal medical input into the discovery of targets and products b) strategic interpretation and mapping of present and future clinical trials and c) formulation and communication of a truthful ambition for the platforms as a whole with partners and shareholders. From November 2011 to March 2014 (2 years 5 months) International Medical Leader Apoptosis/EGFR therapeutic areas @ A broad leadership role in a large and geographically diverse product team with responsibilities for providing European commercial product strategy and tactics and delivering multiple oncology clinical trials from phase one through to phase four including managing a portfolio of over 90 investigator sponsored studies. From September 2010 to October 2011 (1 year 2 months) Medical Director @ Medical Director working on registration and launch of a major oncology therapeutic, cross-portfolio and in-licensing opportunities and KOL and co-op liaison activities. From February 2005 to October 2011 (6 years 9 months) Study team physician @ PI in Phase I, brand development acitivities, phase I, II, III and IV activities as Director's delegate. Significant change management and KOL interaction experience. From October 2001 to February 2005 (3 years 5 months) Research Fellow @ I lead ground breaking research culminating in a first author brief communication in Nature and multiple follow through confirmatory publications. From October 2000 to February 2002 (1 year 5 months) Master of Arts (MA), Medicine @ University of Cambridge From 1991 to 1997 Doctor of Medicine (M.D.) @ University of Cambridge From 1991 to 1996 Dominic Smethurst is skilled in: Oncology, Pharmaceuticals, Biotechnology, Clinical Development, Immunology, Clinical Trials, Life Sciences, Molecular Biology, Drug Discovery, Cell Biology, Biochemistry, Hematology, Clinical, Clinical Research, Cancer
VP Oncology Drug development Services
June 2015 to Present
London, United Kingdom
Prescient Healthcare Group
March 2014 to June 2015
Group Medical director (CMO role) Immunocore/Adaptimmune
November 2011 to March 2014
International Medical Leader Apoptosis/EGFR therapeutic areas
September 2010 to October 2011
February 2005 to October 2011
Study team physician
October 2001 to February 2005
University of Nottingham
October 2000 to February 2002
What company does Dominic Smethurst work for?
Dominic Smethurst works for ICON plc
What is Dominic Smethurst's role at ICON plc?
Dominic Smethurst is VP Oncology Drug development Services
What industry does Dominic Smethurst work in?
Dominic Smethurst works in the Biotechnology industry.
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies